GlassScriptPhysician profile
Shreyank Tripathi
NPI 1285851782
$5,139.85
in general payments reported to CMS, 2019-2025
30 companies · $1,690 in 2025
The $1,690 reported for 2025 was more than what 88% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $541 · 2020: $107 · 2021: $42.58 · 2022: $562 · 2023: $718 · 2024: $1,480 · 2025: $1,690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,546 · Education: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,546.08 |
| Education | $341.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $859.19 | 2019-2025 | Jynarque, Voyxact |
| Bayer Healthcare Pharmaceuticals INC. | $491.35 | 2022-2025 | |
| Amgen INC. | $419.74 | 2019-2025 | Tavneos, Parsabiv, Aranesp |
| Akebia Therapeutics INC | $348.83 | 2019-2025 | Vafseo, Auryxia |
| Mallinckrodt Hospital Products INC. | $341.14 | 2022-2025 | Acthar, Terlivaz |
| Vifor Pharma, INC. | $330.95 | 2019-2025 | Veltassa |
| Fresenius USA Marketing, INC. | $323.02 | 2019-2025 | Velphoro, Velphoro |
| Astrazeneca Pharmaceuticals LP | $226.93 | 2019-2025 | Farxiga, Lokelma |
| Boehringer Ingelheim Pharmaceuticals, INC. | $217.11 | 2023-2025 | Jardiance |
| Ardelyx, INC. | $185.98 | 2023-2025 | Ibsrela |
| Travere Therapeutics, INC. | $182.24 | 2022-2025 | Filspari |
| Opko Pharmaceuticals, LLC | $176.72 | 2023-2025 | Rayaldee |
| Novo Nordisk INC | $145.14 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Aurinia Pharma U.S., INC. | $129.57 | 2022-2025 | Lupkynis |
| Novartis Pharmaceuticals Corporation | $121.50 | 2023-2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calliditas Therapeutics US INC. | $93.18 | 2024-2025 | Tarpeyo |
| Ani Pharmaceuticals, INC. | $86.62 | 2023-2025 | Purified Cortrophin Gel |
| Alexion Pharmaceuticals, INC. | $63.99 | 2019-2024 | Ultomiris |
| Cormedix INC. | $54.48 | 2024 | Defencath |
| Horizon Therapeutics Plc | $54.13 | 2022-2023 | Krystexxa |
| Kyowa Kirin, INC. | $41.93 | 2024 | Crysvita |
| Glaxosmithkline, LLC. | $39.70 | 2023 | Benlysta |
| Scpharmaceuticals INC. | $38.68 | 2025 | |
| Baxter Healthcare | $34.56 | 2019-2023 | Renal - Pd |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $34.39 | 2025 | |
| Genentech USA, INC. | $30.34 | 2019 | |
| Organogenesis INC. | $22.32 | 2021 | |
| Apellis Pharmaceuticals, INC. | $18.01 | 2025 | |
| Janssen Pharmaceuticals, INC | $16.83 | 2023 | Xarelto |
| Melinta Therapeutics, LLC | $11.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shreyank Tripathi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.